Accueil 5 Emplois & Stages ( Page 4 )

Emplois & Stages

Filtres



Offre de stage Master 2 en Sciences Analytiques

Montpellier

Mots-clés : sciences analytiques ; chromatographie liquide ; électrophorèse capillaire ; analyse chirale, spectrométrie de masse ; synthèse peptidique ;…

Mots-clés : sciences analytiques ; chromatographie liquide ; électrophorèse capillaire ; analyse chirale, spectrométrie de masse ; synthèse peptidique ; peptides thérapeutiques.

  • L'Institut des Biomolécules Max Mousseron (IBMM) offre une opportunité exceptionnelle de stage de Master 2 au sein du projet de recherche GLYMS (financement ANR 2023). Ce projet ambitieux s'inscrit dans le domaine des sciences analytiques, visant à explorer en profondeur la chiralité des acides aminés constitutifs des peptides thérapeutiques, et à comprendre son rôle crucial dans leur efficacité biologique.
  • Contexte du Projet : Le projet GLYMS revêt une importance capitale pour la pharmacologie moderne en se penchant sur un défi délicat et méconnu : la chiralité des acides aminés dans les peptides thérapeutiques. Cette caractéristique structurale subtile, mais essentielle, influence directement l’activité biologique des peptides. En tant que stagiaire de Master 2, vous aurez l'occasion de travailler au sein de l'équipe des Sciences Analytiques des Biomolécules de l'IBMM, composée d'experts en séparations analytiques, spectrométrie de masse et chimie des peptides.
  • Missions du Stage : En rejoignant le projet GLYMS en tant que stagiaire, vous contribuerez activement au développement d'outils analytiques avancés destinés à détecter et à caractériser les séquences d’épimérisation au sein des peptides thérapeutiques. Pour cela, vous aurez accès à un parc analytique composé notamment de systèmes séparatifs chiraux (chromatographie liquide et électrophorèse capillaire) et de spectromètres de masse de haute résolution. Votre attention sera particulièrement portée sur les acides aminés aspartique et histidine, réputés pour leur sensibilité à l'épimérisation.
  • Profil Recherché : Nous recherchons un.e étudiant.e en Master 2, passionné.e par les sciences analytiques. Si vous possédez des compétences en techniques séparatives (chromatographie et/ou électrophorèse capillaire), en spectrométrie de masse à haute résolution et en chimie de synthèse des peptides, cela constituera un atout précieux. Votre capacité à travailler de manière autonome, votre créativité et votre motivation à relever des défis scientifiques complexes seront également hautement appréciées.
  • Durée du Stage : Ce stage de Master 2 est prévu pour une durée de 6 mois avec une gratification à hauteur de 4,05 €/heure. Le stage débutera début février 2024. Possibilité de Poursuivre en Thèse : Ce sujet pourra se prolonger par une thèse d’Université dont le financement est acquis auprès de l'Agence Nationale de la Recherche (ANR) dans le cadre du projet GLYMS. Cela offrira une opportunité unique de continuer à contribuer à cette recherche de pointe et de développer vos compétences scientifiques au sein d'un projet à long terme.
  • Comment Postuler : Si cette opportunité de stage vous inspire et que vous aspirez à contribuer à la recherche de pointe dans le domaine de la chimie analytique et des peptides thérapeutiques, nous vous invitons à envoyer votre candidature comprenant votre CV, une lettre de motivation décrivant votre intérêt pour le projet, ainsi que vos relevés de notes, aux adresses e-mail cidessous avant le 27/10/2023 : Dr Adrien Chouchou : adrien.chouchou@umontpellier.fr Pr Catherine Perrin : catherine.perrin@umontpellier.fr Pr Christine Enjalbal : christine.enjalbal@umontpellier.fr Equipe F12 Sciences Analytiques des Biomolécules Institut des Biomolécules Max Mousseron, UMR 5247 (UM CNRS ENSCM), Campus CNRS - 1919, Route de Mende 34293 Montpellier Cedex 5, Franc

Voir plus

Ajouté le 12/10/23

Stage Master : La LC-TASTE : de la molécule à la saveur

Oniris VetAgroBio Nantes - Campus des Sciences de l'Alimentation

Voir plus

Ajouté le 27/09/23

PhD thesis position: Development of a new technology of concurrent 2-dimension separation for characterization of nanoparticles towards nanomedicine applications

Institut Galien Paris Saclay (IGPS), UMR CNRS 8612, PNAS team

The PhD position is granted by the Agence Nationale de la Recherche (ANR) for 36 months starting from the 1st…

The PhD position is granted by the Agence Nationale de la Recherche (ANR) for 36 months starting from the 1st of January 2024. Project Description: This project aims at developing a novel concept and prototyping in separation science, called microscale 2D magneto-electrography (2D-ME). This concept will allow two simultaneous orthogonal migration dimensions in the same microchannel: capillary electrophoresis (CE) under a high electric field and magnetophoresis under a powerful magnetic field gradient. This new concept is expected to be better adapted for size, charge and shape characterization of nano objects (e.g., functionalized nanoparticles). Nanoparticles (NPs), including magnetic nanoparticles (MNPs) play important roles in diagnosis, drug delivery systems and nanomedicine.   Particularly for MNPs, size is also a key parameter when using them as contrast agents in magnetic resonance imaging or tumor radio-sensitization, for magnetic hyperthermia dedicated to thermosensitive drug delivery or cancer treatment [1]. For each family of MNPs, there is often a co-existence of various subpopulations and interferences (especially in biological fluids) with overlapping physical properties, rendering challenging their fine separation and characterization. This requires qualified methods to well separate their subpopulations and characterize them, in order to improve their synthesis to obtain the desired MNPs quality, which is mandatory for biomedical applications and drug delivery systems. Recently, particular attention has been paid to anisotropic MNPs with elongated shapes such as nanorods or nanochains as they exhibit improved magnetic properties for magnetic resonance imaging and magnetic hyperthermia in comparison to their spherical counterparts [2]. Such anisotropic MNPs are also featured by a higher blood circulation time and a prolonged retention in tumor sites compared to spherical NPs, as well as improved interaction with cells thanks to their cylindrical shape. It is however very challenging to separate and characterize anisotropic NPs using conventional separation approaches. From this urgent need, the first 2D-ME prototype to be developed in microfluidic format will be used for resolute charge, size and shape characterization of spheric MNPs and nanorods serving as innovative drug carriers. 2D-ME will also explore and control the nanometric heterogeneity as well as their interactions with biomolecules (e.g., blood proteins) to improve NPs synthesis and the quality of nanomedicine. This interdisciplinary project covers microfluidics, instrumentation, (bio)analytical chemistry, and nanoscience. This project will be supported by the complementary expertise of partners from Institut Néel (for magnetic field design modeling and micro-magnet parterning) and the Inorganic Colloids team of laboratory Physico-chimie des Electrolytes et Nanosystèmes InterfaciauX (PHENIX, Sorbonne university, for synthesis and characterization of magnetic nanoparticles). The PhD student will develop the 2D-ME system and protocols for pre-concentration, separation and characterization of tailored spheric MNPs synthesized by PHENIX. The 2D-ME system in microfluidic format will be developed, with the strong support of our group in purpose-made microfluidic and electrokinetic instrumentation [3, 4]. The PhD student, in close collaboration with Institut Néel, will try to propose different ways to combine the magnetic and electric fields in a microchannel to carry out 2D-ME of standard MNPs. The PhD student will then demonstrate the applicability of the developed system and methodology for separation of magnetic nanorods provided by PHENIX and monitoring their interaction with human plasma proteins to evaluate their behavior under biological conditions.   QUALIFICATION

  • You are highly motivated to work at the boundary between microfluidics, instrumentation, bioanalytical chemistry and nanoscience.
  • You have a master’s degree or equivalent (obtained within 4 years) in either Instrumentation or Analytical Chemistry / Nanoscience / Microfluidics
  • You have practical experience in microfluidics and/or instrumentation and/or microfabrication, with a good sense of analytical chemistry
  • Good knowledge about biochemistry and nanoparticles is advantageous.
  • You have strong communication and presentation skills in English (verbal and written)
  • You enjoy working independently and challenging scientific obstacles with an optimist aptitude.
  Send your application by e-mail before the 1st of October 2023 to thanh-duc.mai@universite-paris-saclay.fr and claire.smadja@universite-paris-saclay.fr including your CV, motivation letter and recommendation letters from your previous supervisors / professors.   Refs: [1]       N.V.T. Nguyen, C. Smadja, M. Taverna, J.M. Siaugue, E. Secret, S. Elmousli, H.L.T. Nguyen, T.D. Mai, Electroosmotic flow modulation for improved electrokinetic preconcentration :  application to  capillary electrophoresis of fluorescent magnetic nanoparticles, Anal. Chim. Acta, 1161 (2021) 338466. [2]        S.E. Mousli-Saada, Elaboration de nanoparticules magnétiques anisotropes et étude de leurs voies d'internalisation cellulaire (PhD thesis), PHENIX - PHysicochimie des Electrolytes et Nanosystèmes InterfaciauX, https://theses.hal.science/tel-03884548 (2022) [3]       N.V.T. Nguyen, C. Smadja, M. Taverna, H.L.T. Nguyen, S. Descroix, T.D. Mai, On-line dual-stage enrichment via magneto-extraction and electrokinetic preconcentration: a new concept and instrumentation for capillary electrophoresis, Anal. Chim. Acta, 1255 (2023) 341141. [4]       T. Liénard--Mayor, J.S. Furter, M. Taverna, H.V. Pham, P.C. Hauser, T.D. Mai, Modular instrumentation for capillary electrophoresis with laser induced fluorescence detection using plug-and-play microfluidic, electrophoretic and optic modules, Anal. Chim. Acta, 1135 (2020) 47-54.

Voir plus

Ajouté le 27/07/23

Post-doc Offer (18 months): New Antibody’s format: strategies to evaluate their aggregation propensity for better developability

Institut Galien Paris Saclay (IGPS), UMR CNRS 8612, PNAS team;

This postdoc is part of the large project ACCREDIA bringing together a network of industrial and academic partners funded by…

This postdoc is part of the large project ACCREDIA bringing together a network of industrial and academic partners funded by the French government aiming at improving the knowledge, skill, and methodologies in antibody developability. The project’s ambition is to create new antibody formats adapted to different routes of administration, in particular, the inhalation one, combining high-throughput antibody screening and engineering, in vitro and in vivo biological activity assessments. To achieve this goal, the immunogenicity of these new format antibodies, mainly due to immunogenic sequences or the formation of aggregates will be also investigated. The aim of the recruited post-doc is ; (i) to develop analytical strategies to characterize and understand the aggregation process and predict antibody sequence features that make an antibody a good candidate in terms of immunogenicity and (ii) to provide bioanalytical tools to monitor degradation/aggregation propensity of these new format antibodies according to the delivery route (lung, nasal…) and their formulation. New mAbs of different formats (Multispecific, ADC, …) will be produced by our partners using inovative engineering processes. Their degradation/aggregation pathways (under different stresses) will be thoroughly investigated (sub-unit involved,….). The impact of the formulations allowing the different routes of administration will also be evaluated. Different orthogonal analytical methods (preparative techniques e.g. FPLC, separation ones like HPLC, SEC, capillary electrophoresis eventually coupled to MS and, Taylor Dispersion Analysis) and spectroscopic ones (e.g. Circular dichroism, DLS, NTA…) will be developed for these purposes. The impact of the degraded forms on innate immunity cells will also be investigated in-vitro in close collaboration with the consortium partners. Laboratory: Institut Galien Paris Saclay (IGPS), UMR CNRS 8612, PNAS team; Henry Moissan building, 17 avenue des sciences, 91400 Orsay (https://www.umr-cnrs8612.universite-paris-saclay.fr/ ) IGPS is an interdisciplinary research institute and is considered as one of the main actors in Europe in the field of nanomedicine and gathers analytical and physico-chemists as well as biologists and pharmacologists. PNAS team has a strong background in protein and peptide analysis. IGPS benefits from the strong presence of national research organizations, numerous state-of-the-art facilities, and scientific platforms of the Paris-Saclay University. Starting date: October/November 2023, 18 months (extension might be possible) Financial support: PEPR contract 2023-2026 (ACCREDIA) Candidate profile: PhD, Analytical chemist interested by cell biology and Immunology. knowledge on mAbs/proteins analysis. To apply: send CV, cover letter and one or two references to claire.smadja@universite-paris-saclay.fr and myriam.taverna@universite-paris-saclay.fr Salary (gross) : ranging from 2889,51 to 4082,90 € per month depending on experience

Voir plus

Ajouté le 26/07/23

Offre de Thèse : Innovative sampling and suspect/non-targeted screening methods for exploring human perinatal exposure to chemicals of emerging concern

Nantes (FR-44)

Background Conventional sampling and targeted quantitative methods dedicated to chemical analyses are available to support environmental, food and human monitoring,…

Background Conventional sampling and targeted quantitative methods dedicated to chemical analyses are available to support environmental, food and human monitoring, risk assessment, and risk management decisions. However, these approaches sometimes still suffer from a lack of sensitivity to characterize lowest exposed populations, a lack of feasibility for large population studies, and importantly only capture a limited number of a priori known and selected markers of exposure. Capturing the complex real human chemical exposome requires new conceptual frameworks and innovative methodological approaches, built on the latest generation of cutting-edge instrumentation that open the door to more rapid, high throughput, and holistic marker’s detection and identification. Combining innovative sampling (dry bloodspot, silicone wristbands) and/or biological matrices (cord blood, placenta, meconium…) with suspect and non-targeted screening approaches based on high resolution mass spectrometry (HRMS) today appear as promising methodological alternatives to widen our knowledge of the human chemical exposome. As formulated by several agencies (e.g. EFSA), early stage human exposure appears in particular as a high concern not yet well addressed, both in terms of risk assessment and link to health impact at latest stages (DoHAD concept). The aim of this project is to develop and conduct a proof-of-concept permitting to assess the performances, and illustrate the usefulness, of those innovative methods, as complementary to conventional and targeted approaches, with a focus on human samples collected from mother-newborn/child individuals. Objectives In this context, a research project is open for a Ph.D. candidate. This project aims to develop innovative analytical strategies focusing on perinatal exposure profiling via multidimensional and high-resolution mass spectrometry coupled with different types of chromatographic separations (LC-Q-Exactive/LC-Q-TOF/GC-Q-Exactive). The Ph.D. student's research work will thus consist of sample preparation, data generation, data analysis, and treatment to gain access to the characterization of the chemical exposure of individuals (Exposomics). Moreover, an additional part will be dedicated to evaluating the new sampling methods and comparing them to more invasive conventional techniques. This Ph.D. project is a part of a large European consortium on chemical exposure (PARC project “Partnership for Assessment of Risk of Chemicals”, EU Horizon EU Cofund, 2022-2029, https://www.eu-parc.eu/) – assembling more than 200 institutions from 28 countries. This consortium will offer the candidate a large networking and international experience. Supervisors Dr. Jean-Philippe ANTIGNAC Dr. Tarek MOUFAWAD Qualifications We are looking for a highly motivated scientist with a master degree in characterization of human exposure to chemicals. In detail, the candidate is expected to possess:  Strong chemical background with a M.Sc. in Chemistry, Chemical Engineering, Analytical Chemistry or equivalent  Hands on experience with analytical method development and advanced data analysis within chromatography and mass spectrometry (multidimensional and/or high resolution MS) workflows  Experience or knowledge about one or more of the following areas will be an advantage: o Chemical contaminants o Exposomics o Multivariate data analysis  Good laboratory skills  Good collaboration and communication skills (written and spoken English)  Structured and analytical working approach Salary The period of employment is 3 year, gross salary of 2044.12 €/month. Application Please submit your application before 30 July 2023. Applications must be submitted to jean-philippe.antignac@oniris-nantes.fr and tarek.moufawad@oniris-nantes.fr as one pdf file containing all materials to be given consideration. The file must include:  A covering letter  A curriculum vitae  Supporting letters

Voir plus

Ajouté le 10/07/23